BHC
Price
$7.06
Change
-$0.06 (-0.84%)
Updated
Jul 3 closing price
Capitalization
3.86B
24 days until earnings call
PAHC
Price
$28.00
Change
+$0.06 (+0.21%)
Updated
Jul 3 closing price
Capitalization
523.71M
52 days until earnings call
Interact to see
Advertisement

BHC vs PAHC

Header iconBHC vs PAHC Comparison
Open Charts BHC vs PAHCBanner chart's image
Bausch Health Companies
Price$7.06
Change-$0.06 (-0.84%)
Volume$1.18M
Capitalization3.86B
Phibro Animal Health
Price$28.00
Change+$0.06 (+0.21%)
Volume$322.71K
Capitalization523.71M
BHC vs PAHC Comparison Chart in %
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. PAHC commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Hold and PAHC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (BHC: $7.06 vs. PAHC: $28.00)
Brand notoriety: BHC: Notable vs. PAHC: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BHC: 58% vs. PAHC: 122%
Market capitalization -- BHC: $3.86B vs. PAHC: $523.71M
BHC [@Pharmaceuticals: Other] is valued at $3.86B. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • BHC’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 5 TA indicator(s) are bullish while PAHC’s TA Score has 5 bullish TA indicator(s).

  • BHC’s TA Score: 5 bullish, 4 bearish.
  • PAHC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BHC and PAHC are a good buy in the short-term.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а +10.14% price change this week, while PAHC (@Pharmaceuticals: Other) price change was +11.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

BHC is expected to report earnings on Jul 30, 2025.

PAHC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($3.86B) has a higher market cap than PAHC($524M). PAHC has higher P/E ratio than BHC: PAHC (34.11) vs BHC (13.39). PAHC YTD gains are higher at: 34.666 vs. BHC (-12.407). BHC has higher annual earnings (EBITDA): 2.2B vs. PAHC (83.7M). BHC has more cash in the bank: 947M vs. PAHC (92.5M). PAHC has less debt than BHC: PAHC (513M) vs BHC (22.4B). BHC has higher revenues than PAHC: BHC (8.76B) vs PAHC (982M).
BHCPAHCBHC / PAHC
Capitalization3.86B524M736%
EBITDA2.2B83.7M2,631%
Gain YTD-12.40734.666-36%
P/E Ratio13.3934.1139%
Revenue8.76B982M892%
Total Cash947M92.5M1,024%
Total Debt22.4B513M4,366%
FUNDAMENTALS RATINGS
BHC vs PAHC: Fundamental Ratings
BHC
PAHC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
10062
PRICE GROWTH RATING
1..100
3938
P/E GROWTH RATING
1..100
9888
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (28) in the Pharmaceuticals Major industry is in the same range as BHC (35) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to BHC’s over the last 12 months.

PAHC's Profit vs Risk Rating (77) in the Pharmaceuticals Major industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to BHC’s over the last 12 months.

PAHC's SMR Rating (62) in the Pharmaceuticals Major industry is somewhat better than the same rating for BHC (100) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than BHC’s over the last 12 months.

PAHC's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as BHC (39) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to BHC’s over the last 12 months.

PAHC's P/E Growth Rating (88) in the Pharmaceuticals Major industry is in the same range as BHC (98) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCPAHC
RSI
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
72%
Momentum
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
71%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
Bearish Trend 20 days ago
78%
Bearish Trend 17 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
68%
Aroon
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GOFIX19.080.29
+1.54%
GMO Resources III
TGVFX53.260.56
+1.06%
Touchstone Dynamic Large Cap Growth A
FDECX23.090.20
+0.87%
Fidelity Advisor Capital Development C
MGPSX77.600.59
+0.77%
ProFunds Mid Cap Growth Svc
GHAIX44.61N/A
N/A
VanEck Global Resources Fund I

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and TLRY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
-0.84%
TLRY - BHC
28%
Poorly correlated
+11.03%
PAHC - BHC
26%
Poorly correlated
+0.21%
ELAN - BHC
26%
Poorly correlated
-0.54%
SWDCF - BHC
25%
Poorly correlated
N/A
TEVA - BHC
25%
Poorly correlated
-0.23%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+0.21%
PBH - PAHC
48%
Loosely correlated
-0.25%
AMRX - PAHC
47%
Loosely correlated
+0.60%
ZTS - PAHC
43%
Loosely correlated
+0.06%
VTRS - PAHC
40%
Loosely correlated
-0.21%
ELAN - PAHC
38%
Loosely correlated
-0.54%
More